stars 1 stars 2 stars 3

SINERGIUM BIOTECH producirá vacunas antigripales estacionales y pandémicas La nueva planta industrial contará con tecnología de última generación. Argentina será, por lo tanto, parte de un reducido grupo de naciones capaces de producir y exportar vacunas contra la influenza y productos biotecnológicos. Nueva Busqueda:

SINERGIUM Biotech Questions

The SINERGIUM Biotech annual revenue was $34.5 million in 2026.

Leonardo Ruiz Díaz is the Director comercial of SINERGIUM Biotech.

216 people are employed at SINERGIUM Biotech.

SINERGIUM Biotech is based in Garín, Buenos Aires.

The NAICS codes for SINERGIUM Biotech are [5417, 541, 54, 54171, 541713].

The SIC codes for SINERGIUM Biotech are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users